Last reviewed · How we verify
Sample
At a glance
| Generic name | Sample |
|---|---|
| Also known as | questionnary to obtain an hemorrhagic score |
| Sponsor | University Hospital, Clermont-Ferrand |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Diagnostic and PROgnostic BIOmarkers Before and After Kidney Transplantation (N/A)
- Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients With AML Undergoing Allografting: Assessment of Feasibility and Efficacy (N/A)
- Sudden Cardiac Death in Congenital Heart Diseases With a Systemic Right Ventricle (N/A)
- Analysis of Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation (N/A)
- Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo (N/A)
- The Prospective Role of Epigenetics in Attention-deficit/Hyperactivity Disorderdeficit/Hyperactivity Disorder (N/A)
- Impact of Inseminated Volume and Live Birth Rates After Intrauterine Insemination (IUI) With Donor Sperm (dIUI): A Prospective Randomized COntrolled Trial (NA)
- The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics (PDD): a Clinical Pilot Study (Phase 2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sample CI brief — competitive landscape report
- Sample updates RSS · CI watch RSS
- University Hospital, Clermont-Ferrand portfolio CI